{
  "id": 2370,
  "text": "91.Landoni, F., et al.Class II versus class III radical hysterectomy in stage IB-IIA cervical cancer: a prospective randomized study.Gynecol Oncol 80, 3- 12 (2001).92.Eralp, Y., et al.Prognostic factors and survival in patients with metastatic or recurrent carcinoma of the uterine cervix.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: 91.Landoni, F., et al.Class II versus class III radical hysterectomy in stage IB-IIA cervical cancer: a prospective randomized study.Gynecol Oncol 80, 3- 12 (2001).92.Eralp, Y., et al.Prognostic factors and survival in patients with metastatic or recurrent carcinoma of the uterine cervix.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "影响复发或转移性宫颈癌患者预后的因素主要包括以下几个方面：\n\n1. **肿瘤的病理类型和分化程度**：低分化或非鳞状细胞类型的宫颈癌往往预后较差。\n\n2. **病变范围和转移部位**：肿瘤转移的广泛程度、是否累及重要器官（如肝、肺或远端淋巴结）是重要的预后指标。局限性复发的病例比伴远处转移的病例预后更好。\n\n3. **治疗方式**：接受积极治疗（如手术、化疗或放疗）的患者，其生存率通常高于未接受治疗或仅接受姑息治疗的患者。\n\n4. **治疗前的体能状态（ECOG评分）**：患者的整体健康状况和生活质量显著影响治疗耐受性及生存时间。\n\n5. **肿瘤标志物水平**：如血清SCC抗原水平的升高与复发风险及更差的预后相关。\n\n6. **癌症分期**：更高分期的肿瘤常伴随更高的复发和转移可能性。\n\n综合考虑上述因素能够为提供个体化治疗和改善预后提供指导。",
  "query": "什么是影响复发或转移性宫颈癌患者预后的因素？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 什么是影响复发或转移性宫颈癌患者预后的因素？\n\n<reference text>: 91.Landoni, F., et al.Class II versus class III radical hysterectomy in stage IB-IIA cervical cancer: a prospective randomized study.Gynecol Oncol 80, 3- 12 (2001).92.Eralp, Y., et al.Prognostic factors and survival in patients with metastatic or recurrent carcinoma of the uterine cervix.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "影响复发或转移性宫颈癌患者预后的因素主要包括以下几个方面：\n\n1. **肿瘤的病理类型和分化程度**：低分化或非鳞状细胞类型的宫颈癌往往预后较差。\n\n2. **病变范围和转移部位**：肿瘤转移的广泛程度、是否累及重要器官（如肝、肺或远端淋巴结）是重要的预后指标。局限性复发的病例比伴远处转移的病例预后更好。\n\n3. **治疗方式**：接受积极治疗（如手术、化疗或放疗）的患者，其生存率通常高于未接受治疗或仅接受姑息治疗的患者。\n\n4. **治疗前的体能状态（ECOG评分）**：患者的整体健康状况和生活质量显著影响治疗耐受性及生存时间。\n\n5. **肿瘤标志物水平**：如血清SCC抗原水平的升高与复发风险及更差的预后相关。\n\n6. **癌症分期**：更高分期的肿瘤常伴随更高的复发和转移可能性。\n\n综合考虑上述因素能够为提供个体化治疗和改善预后提供指导。"
}